APA
Borad M. J., Soman A. D., Benjamin M., Casa D., Tembe W. D., Piper B. F., Ramanathan R., Tibes R., Jameson G., Ansaldo K. & Von Hoff D. D. (20140211). Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials. : Investigational new drugs.
Chicago
Borad Mitesh J, Soman Arundhati D, Benjamin Martin, Casa Daniel, Tembe Waibhav D, Piper Barbara F, Ramanathan Ramesh, Tibes Raoul, Jameson Gayle, Ansaldo Karen and Von Hoff Daniel D. 20140211. Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials. : Investigational new drugs.
Harvard
Borad M. J., Soman A. D., Benjamin M., Casa D., Tembe W. D., Piper B. F., Ramanathan R., Tibes R., Jameson G., Ansaldo K. and Von Hoff D. D. (20140211). Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials. : Investigational new drugs.
MLA
Borad Mitesh J, Soman Arundhati D, Benjamin Martin, Casa Daniel, Tembe Waibhav D, Piper Barbara F, Ramanathan Ramesh, Tibes Raoul, Jameson Gayle, Ansaldo Karen and Von Hoff Daniel D. Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials. : Investigational new drugs. 20140211.